Atopic Dermatitis in Adulthood Linked to Increased Risk for VTE
Researchers sought to evaluate patients with atopic dermatitis for risk of incident venous thromboembolism (deep vein thrombosis and/or pulmonary embolism).
Researchers sought to evaluate patients with atopic dermatitis for risk of incident venous thromboembolism (deep vein thrombosis and/or pulmonary embolism).
A retrospective study of nearly 1.3 million babies evaluated whether maternal use of antibiotics during pregnancy may increase childhood risk for atopic dermatitis.
Resilia Pharmaceuticals has announced the relaunch of Solace Cream for the treatment of signs and symptoms of eczema.
The approval was based on data from previous studies that included 124 adolescent patients, as well as the phase 3 JADE TEEN study.
Results showed a significantly greater proportion of patients treated with tapinarof cream achieved vIGA-AD success compared with vehicle cream.
A cohort study of mother and child pairs investigates the association between mode of delivery and atopic dermatitis in children 5 years of age and younger.
The INTEGUMENT-2 trial included patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.
Theoretical annual costs of OTC moisturizer are compared with costs of atopic dermatitis; Medicaid coverage is also reviewed.
A new American Academy of Dermatology (AAD) guideline describes available evidence on comorbidities associated with atopic dermatitis (AD) in adults.
The approval was based on data from a phase 3 study that evaluated Dupixent added to low potency topical corticosteroids in children aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.